Microneedle array sensor applicator device

- Biolinq Incorporated
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective view of a microneedle array sensor applicator device showing the new design;

FIG. 2 is a front view thereof;

FIG. 3 is a right side view thereof;

FIG. 4 is a rear view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a top plan view thereof; and,

FIG. 7 is a bottom plan view thereof.

The broken lines illustrate portions of the microneedle array sensor applicator device that form no part of the claimed design.

Claims

The ornamental design for a microneedle array sensor applicator device, as shown and described.

Referenced Cited
U.S. Patent Documents
D178118 June 1956 Enos
D315914 April 2, 1991 Chen
D438794 March 13, 2001 Miles
D444594 July 3, 2001 Angeletta
6855131 February 15, 2005 Trautman et al.
7097631 August 29, 2006 Trautman et al.
D544298 June 12, 2007 Eide
7582059 September 1, 2009 Funderburk et al.
7946984 May 24, 2011 Brister et al.
8094009 January 10, 2012 Allen et al.
8125331 February 28, 2012 Allen et al.
8130095 March 6, 2012 Allen et al.
8175673 May 8, 2012 Say et al.
8252229 August 28, 2012 Thomas et al.
8267889 September 18, 2012 Cantor et al.
8280475 October 2, 2012 Brister et al.
8284046 October 9, 2012 Allen et al.
D681877 May 7, 2013 Curry
8579862 November 12, 2013 Kobayashi et al.
8652043 February 18, 2014 Drucker et al.
8753318 June 17, 2014 Trautman et al.
8758298 June 24, 2014 Cantor et al.
8764657 July 1, 2014 Curry et al.
8821446 September 2, 2014 Trautman et al.
D717100 November 11, 2014 Moser
9008745 April 14, 2015 Pushpala et al.
9055901 June 16, 2015 Brister et al.
9101305 August 11, 2015 Larson et al.
9119945 September 1, 2015 Simons et al.
9174035 November 3, 2015 Ringsred et al.
9215992 December 22, 2015 Donnay et al.
9357951 June 7, 2016 Simpson et al.
9402544 August 2, 2016 Yee et al.
9402570 August 2, 2016 Pace et al.
9415198 August 16, 2016 McAllister
9492647 November 15, 2016 Stumber et al.
9610401 April 4, 2017 Antonio et al.
9615779 April 11, 2017 Pryor et al.
9636060 May 2, 2017 Feldman et al.
9642568 May 9, 2017 Shah et al.
9687640 June 27, 2017 Trautman et al.
9717843 August 1, 2017 Grucela et al.
9737247 August 22, 2017 Wang et al.
9743870 August 29, 2017 Wang et al.
9782574 October 10, 2017 Simmers
9789249 October 17, 2017 Frederickson et al.
9814414 November 14, 2017 Brister et al.
D806254 December 26, 2017 Im
9844328 December 19, 2017 Simpson et al.
9933387 April 3, 2018 McCanna et al.
9949642 April 24, 2018 Love et al.
9968742 May 15, 2018 Van Antwerp et al.
10010280 July 3, 2018 Donnay et al.
10010707 July 3, 2018 Colburn et al.
D827682 September 4, 2018 Anderson
10092207 October 9, 2018 Windmiller
10136846 November 27, 2018 Wang et al.
10213139 February 26, 2019 Rao et al.
10213141 February 26, 2019 Cole et al.
10278732 May 7, 2019 Schoonmaker et al.
10300260 May 28, 2019 Wirtanen et al.
10406339 September 10, 2019 Simmers
10413183 September 17, 2019 Antonio et al.
10492685 December 3, 2019 Bernstein et al.
10492708 December 3, 2019 Windmiller
D875254 February 11, 2020 Cooke et al.
10595754 March 24, 2020 Pushpala et al.
10596295 March 24, 2020 Larson et al.
10674944 June 9, 2020 Pace
10709834 July 14, 2020 Chiu et al.
10863944 December 15, 2020 Gray et al.
10898115 January 26, 2021 Halac et al.
10932699 March 2, 2021 Lin et al.
10973443 April 13, 2021 Funderburk et al.
10993646 May 4, 2021 Scott et al.
11045142 June 29, 2021 Windmiller et al.
D924406 July 6, 2021 Yee
11058329 July 13, 2021 Simpson et al.
11071478 July 27, 2021 Rao et al.
D928119 August 17, 2021 Walter
11122043 September 14, 2021 Love et al.
11172851 November 16, 2021 Pushpala et al.
11357430 June 14, 2022 Pushpala et al.
11406818 August 9, 2022 Windmiller
11517222 December 6, 2022 Pushpala et al.
D980986 March 14, 2023 Rao
11654270 May 23, 2023 Mansfield et al.
D988160 June 6, 2023 Morelock
11672965 June 13, 2023 Mansfield et al.
D996999 August 29, 2023 Morelock
D997362 August 29, 2023 Donnay
D999913 September 26, 2023 Rao
D1006235 November 28, 2023 Rao
D1008021 December 19, 2023 Jensen
20020087182 July 4, 2002 Trautman et al.
20040236251 November 25, 2004 Roe
20050096586 May 5, 2005 Trautman et al.
20050283114 December 22, 2005 Bresina
20080114280 May 15, 2008 Stafford
20080183144 July 31, 2008 Trautman et al.
20080242961 October 2, 2008 Brister et al.
20100056873 March 4, 2010 Allen et al.
20110082484 April 7, 2011 Saravia et al.
20110106126 May 5, 2011 Love et al.
20110190603 August 4, 2011 Stafford
20110191044 August 4, 2011 Stafford
20110319729 December 29, 2011 Donnay et al.
20120123387 May 17, 2012 Gonzalez et al.
20120197222 August 2, 2012 Donnay et al.
20120303043 November 29, 2012 Donnay
20140275907 September 18, 2014 Feldman et al.
20140330209 November 6, 2014 Frederickson et al.
20140336487 November 13, 2014 Wang et al.
20150173661 June 25, 2015 Myles
20150351674 December 10, 2015 Thomas et al.
20160029931 February 4, 2016 Salas-Boni et al.
20170361079 December 21, 2017 Trautman et al.
20180317820 November 8, 2018 Pace et al.
20190059796 February 28, 2019 Larson et al.
20190120785 April 25, 2019 Halac et al.
20190125223 May 2, 2019 Wang et al.
20190133501 May 9, 2019 Rao et al.
20190133510 May 9, 2019 El Kaliouby et al.
20190239825 August 8, 2019 Kumar et al.
20190309433 October 10, 2019 Sattayasamitsathit et al.
20190336053 November 7, 2019 Halac et al.
20190339224 November 7, 2019 Bhavaraju et al.
20200037939 February 6, 2020 Castagna et al.
20200085341 March 19, 2020 Windmiller
20200101286 April 2, 2020 Windmiller et al.
20200138346 May 7, 2020 Brister et al.
20200178853 June 11, 2020 Pushpala et al.
20200209179 July 2, 2020 Bohm et al.
20200214566 July 9, 2020 Allen et al.
20200254240 August 13, 2020 Windmiller et al.
20200297997 September 24, 2020 Windmiller et al.
20200330010 October 22, 2020 Barry et al.
20200375455 December 3, 2020 Van Tassel et al.
20210000399 January 7, 2021 Curry et al.
20210007651 January 14, 2021 Donnay et al.
20210038131 February 11, 2021 Li et al.
20210076987 March 18, 2021 Stafford
20210133126 May 6, 2021 Yamakita et al.
20210142912 May 13, 2021 Belliveau et al.
20210186425 June 24, 2021 Rodriguez et al.
20210187286 June 24, 2021 Windmiller et al.
20210196162 July 1, 2021 Halac et al.
20210204841 July 8, 2021 Thomas et al.
20210219877 July 22, 2021 Baker et al.
20210236057 August 5, 2021 Pushpala et al.
20210260257 August 26, 2021 McCanless et al.
20210308009 October 7, 2021 Cho et al.
20210315493 October 14, 2021 Pace et al.
20210321914 October 21, 2021 Brister et al.
20210321942 October 21, 2021 Pushpala et al.
20210379370 December 9, 2021 Windmiller
20210393201 December 23, 2021 Morelock et al.
20220031209 February 3, 2022 Windmiller et al.
20220031244 February 3, 2022 Windmiller et al.
20220079481 March 17, 2022 Pushpala et al.
20220080678 March 17, 2022 Cole et al.
20220087610 March 24, 2022 Pushpala et al.
20220125344 April 28, 2022 Pushpala et al.
20220151516 May 19, 2022 Wang et al.
20220175278 June 9, 2022 Campbell et al.
20220370011 November 24, 2022 Windmiller et al.
20230033467 February 2, 2023 Pushpala et al.
20230074798 March 9, 2023 Tangney
20230094419 March 30, 2023 Mansfield, III et al.
20230099617 March 30, 2023 Mansfield, III et al.
20230137258 May 4, 2023 Windmiller
20230190147 June 22, 2023 Campbell et al.
20230256220 August 17, 2023 Mansfield, III et al.
20230301552 September 28, 2023 Mallires et al.
20230310823 October 5, 2023 Mansfield, III et al.
Foreign Patent Documents
2015227515 May 2017 AU
2 532 305 December 2012 EP
D1707722 February 2022 JP
WO-2007/097754 August 2007 WO
WO-2013/066854 May 2013 WO
WO-2014/055456 April 2014 WO
WO-2018/071265 April 2018 WO
WO-2019/084023 May 2019 WO
WO-2019/236859 December 2019 WO
WO-2019/236876 December 2019 WO
WO-2020/231405 November 2020 WO
WO-2021/101857 May 2021 WO
WO-2021/158372 August 2021 WO
WO-2021/257624 December 2021 WO
WO-2023/055755 April 2023 WO
WO-2023/064877 April 2023 WO
WO-2023/133468 July 2023 WO
Other references
  • Freestyle Libre 3 Sensor, usmeddirect.com, [online], [site visited Sep. 21, 2023], Available from internet, URL: https://www.usmeddirect.com/products/freestyle-libre-3-sensor-prescription-required (Year: 2023).
  • Dexcom G7 Sensor, pharmalynk.com, [online], [site visited Sep. 21, 2023], Available from internet, URL: https://store.pharmalynk.com/products/dexcom-g7-cgm (Year: 2023).
  • Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
  • American Diabetes Association® Press Release (2020). “American Diabetes Association® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
  • Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
  • Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
  • Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
  • Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
  • Dexcom (2020). Analyst Day Presentation, 19 total pages.
  • Dexcom (2020). Analyst Day Presentation, 27 total pages.
  • Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
  • Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
  • French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
  • Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24.
  • Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study),” J. Diab. Scl. Tech. 12:1211-1219.
  • Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
  • International Search Report mailed on Sep. 9, 2021, for PCT Application No. PCT/US2021/037511, filed on Jun. 15, 2021, 2 pages.
  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
  • Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring with Glycemic Control and Acute Metabolic Events Among Patients with Insulin-Treated Diabetes,” JAMA 325:2273-2284.
  • Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin a Randomized Clinical Trial,” JAMA 325:2262-2272.
  • McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
  • Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Blomed. Optics 9:274-281.
  • Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
  • Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
  • Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
  • Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.
  • Written Opinion of the International Searching Authority mailed on Sep. 9, 2021, for PCT Application No. PCT/US2021/037511, filed on Jun. 15, 2021, 6 pages.
  • Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. doi: 10.7759/cureus.11195.
  • Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. (2008) Jun. 80(3): 371-379. doi:10.1016/j.diabres.2008.01.006.
  • Barrett et al., “Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
  • Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
  • Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
  • Ehrhardt et al., “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring ” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
  • Ehrhardt et al., “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
  • Ehrhardt et al., “Continuous Glucose Monitoring as a Behavior Modification Tool” Clin Diabetes. Apr. 2020;38(2):126-131. doi: 10.2337/cd19-0037.
  • Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
  • Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
  • Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
  • International Search Report and Written Opinion mailed on Mar. 20, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 26 pages.
  • International Search Report and Written Opinion mailed on May 22, 2023, for PCT Application No. PCT/US2023/060177, filed on Jan. 5, 2023, 20 pages.
  • Invitation to Pay Additional Fees mailed on Jan. 26, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 22 pages.
  • Invitation to Pay Additional Fees mailed on Mar. 28, 2023, for PCT Application No. PCT/US2023/060177, filed on Jan. 5, 2023, 15 pages.
  • Non-Final Office Action mailed on Apr. 25, 2023, for U.S. Appl. No. 17/348,651, filed Jun. 15, 2021, 24 pages.
  • Non-Final Office Action mailed on Dec. 7, 2022, for U.S. Appl. No. 17/954,289, filed Sep. 27, 2022, 7 pages.
  • Non-Final Office Action mailed on Sep. 8, 2023, for U.S. Appl. No. 18/139,308, filed Apr. 25, 2023, 7 pages.
  • Notice of Allowance mailed on Jan. 26, 2023, for U.S. Appl. No. 17/954,289, filed Sep. 27, 2022, 9 pages.
  • Notice of Allowance mailed on Jan. 3, 2023, for U.S. Appl. No. 17/954,293, filed Sep. 27, 2022, 8 pages.
  • Notice of Allowance mailed on Sep. 12, 2023, for U.S. Appl. No. 18/139,302, filed Apr. 25, 2023, 8 pages.
  • Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
  • Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):837-853.
  • Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
  • Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
  • World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
  • Written Opinion (Second Opinion) of the International Preliminary Examining Authority mailed on May 25, 2023, for PCT Application No. PCT/US2022/044950, filed on Sep. 27, 2022, 14 pages.
  • Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients with Type 2 Diabetes in Primary Care Settings: A Randomized Trial” JAMA Intern Med. Jul. 2017; 177(7):920-929.
Patent History
Patent number: D1033641
Type: Grant
Filed: Dec 17, 2021
Date of Patent: Jul 2, 2024
Assignee: Biolinq Incorporated (San Diego, CA)
Inventor: David Michael Morelock (Escondido, CA)
Primary Examiner: Samantha Q Lawrence
Assistant Examiner: Thanh Luu Wong
Application Number: 29/819,952
Classifications
Current U.S. Class: Cutting, Abrading, Scraping Or Puncturing (31) (D24/146)